J-trx opt/mkt

Question 1

Factors that Influence Treament

Answer 1

• Specific pathogen causing onychomycosis
• potential adverse events associated with trx
• Potential drug interactions
• Dosage schedule and patients lifestyle
• patient compliance
• Cost
• age/health of patient

Question 2

Mechanical Trx

Answer 2

Debridement, avulsion and laser therapy

Question 3

Debridement

Answer 3

removal of foreign material and dead or damaged tissue

Question 4

Avulsion

Answer 4

Removal of all or part of the nail plate

Question 5

OTC

Answer 5

Formula 3/Proclearz (1% tolnaftate) - mild fungicidal/antifungal

Lotrimin (Clotrimazole 1%) -Antifungal spec for yeast

Question 6

Oral Antifungal Agents

Answer 6

Highest rates of complete/mycological cure
Primary concern is potential drug interaction and adverse events including liver.

ie. terbinafine (3-4 month therapy)and itraconazole (12wk therapy)

Question 7

Topical Antifungal Agents

Answer 7

Primary therapy in mild infectiosn
Pallative therapy for those unable to take oral
Prophylactic therapy to help prevent infection

ie Penlac (Ciclopirox) 
    Kerydin (tavaborole)

Question 8

Lamisil ( Terbinafine)

Answer 8

250mg tablet
1x a day for 12wks

Warnings-Hepatoxicity

Question 9

Penlac ( Ciclopirox)

Answer 9

Lacquer solution in 6.6ml bottle w/screw caps wit brush
mild to mod infection
daily for 48wks